This content is from:APP亚博娱乐
PE Firms Eye Glaxosmithkline Portfolio
Glaxosmithkline is seeking to sell its portfolio of consumer products worth £1.5-2 billion.
Glaxosmithkline正寻求sellitsportfolio of consumer products worth £1.5-2 billion,The Wall Street Journalreports. The potential bidders for the deal includeAdventInternational,WarburgPincusandCinven.
The over-the-counter products, which are primarily sold in Europe and the U.S., created revenues of nearly £500 million in 2010.Goldman Sachsis organizing the auction of the portfolio.
Click here for the story fromThe Wall Street Journal.
Click here for additional coverage fromReuters.